These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 25760445

  • 1. Inhibition of the JAK2/STAT3 signaling pathway exerts a therapeutic effect on osteosarcoma.
    Yan J, Wang Q, Zou K, Wang L, Schwartz EB, Fuchs JR, Zheng Z, Wu J.
    Mol Med Rep; 2015 Jul; 12(1):498-502. PubMed ID: 25760445
    [Abstract] [Full Text] [Related]

  • 2. 4-Methoxydalbergione suppresses growth and induces apoptosis in human osteosarcoma cells in vitro and in vivo xenograft model through down-regulation of the JAK2/STAT3 pathway.
    Park KR, Yun HM, Quang TH, Oh H, Lee DS, Auh QS, Kim EC.
    Oncotarget; 2016 Feb 09; 7(6):6960-71. PubMed ID: 26755649
    [Abstract] [Full Text] [Related]

  • 3. Pterostilbene exerts antitumor activity against human osteosarcoma cells by inhibiting the JAK2/STAT3 signaling pathway.
    Liu Y, Wang L, Wu Y, Lv C, Li X, Cao X, Yang M, Feng D, Luo Z.
    Toxicology; 2013 Feb 08; 304():120-31. PubMed ID: 23313376
    [Abstract] [Full Text] [Related]

  • 4. Small molecules, LLL12 and FLLL32, inhibit STAT3 and exhibit potent growth suppressive activity in osteosarcoma cells and tumor growth in mice.
    Onimoe GI, Liu A, Lin L, Wei CC, Schwartz EB, Bhasin D, Li C, Fuchs JR, Li PK, Houghton P, Termuhlen A, Gross T, Lin J.
    Invest New Drugs; 2012 Jun 08; 30(3):916-26. PubMed ID: 21340507
    [Abstract] [Full Text] [Related]

  • 5. MiR362-3p Alleviates Osteosarcoma by Regulating the IL6ST/JAK2/STAT3 Pathway in Vivo and in Vitro.
    Hu Y, Li J, Liu C, Zhang X, Wang Y, Lin J, Peng Z, Zhu L.
    Technol Cancer Res Treat; 2024 Jun 08; 23():15330338241261616. PubMed ID: 39051528
    [Abstract] [Full Text] [Related]

  • 6. Liensinine Inhibits Osteosarcoma Growth by ROS-Mediated Suppression of the JAK2/STAT3 Signaling Pathway.
    Jia F, Liu Y, Dou X, Du C, Mao T, Liu X.
    Oxid Med Cell Longev; 2022 Jun 08; 2022():8245614. PubMed ID: 35116094
    [Abstract] [Full Text] [Related]

  • 7. The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines.
    Fossey SL, Bear MD, Lin J, Li C, Schwartz EB, Li PK, Fuchs JR, Fenger J, Kisseberth WC, London CA.
    BMC Cancer; 2011 Mar 28; 11():112. PubMed ID: 21443800
    [Abstract] [Full Text] [Related]

  • 8. Silencing of cytoskeleton-associated protein 2 represses cell proliferation and induces cell cycle arrest and cell apoptosis in osteosarcoma cells.
    Zhang S, Wang Y, Chen S, Li J.
    Biomed Pharmacother; 2018 Oct 28; 106():1396-1403. PubMed ID: 30119212
    [Abstract] [Full Text] [Related]

  • 9. Physalin A exerts anti-tumor activity in non-small cell lung cancer cell lines by suppressing JAK/STAT3 signaling.
    Zhu F, Dai C, Fu Y, Loo JF, Xia D, Gao SP, Ma Z, Chen Z.
    Oncotarget; 2016 Feb 23; 7(8):9462-76. PubMed ID: 26843613
    [Abstract] [Full Text] [Related]

  • 10. STAT3 inhibitor, cucurbitacin I, is a novel therapeutic agent for osteosarcoma.
    Oi T, Asanuma K, Matsumine A, Matsubara T, Nakamura T, Iino T, Asanuma Y, Goto M, Okuno K, Kakimoto T, Yada Y, Sudo A.
    Int J Oncol; 2016 Dec 23; 49(6):2275-2284. PubMed ID: 27840900
    [Abstract] [Full Text] [Related]

  • 11. CircRNA-CIRH1A Promotes the Development of Osteosarcoma by Regulating PI3K/AKT and JAK2/STAT3 Signaling Pathways.
    Zhang M, Wang X, Zhao J, Yan J, He X, Qin D, Liang F, Tong K, Wang J.
    Mol Biotechnol; 2024 Sep 23; 66(9):2241-2253. PubMed ID: 37608076
    [Abstract] [Full Text] [Related]

  • 12. 4-parvifuran inhibits metastatic and invasive actions through the JAK2/STAT3 pathway in osteosarcoma cells.
    Yun HM, Park KR, Quang TH, Oh H, Hong JT, Kim YC, Kim EC.
    Arch Pharm Res; 2017 May 23; 40(5):601-609. PubMed ID: 28386742
    [Abstract] [Full Text] [Related]

  • 13. Novel quinazoline derivatives exhibit antitumor activity by inhibiting JAK2/STAT3.
    Qiao H, Zhao D, Shi H, Ren K, Li J, Li E.
    Oncol Rep; 2015 Oct 23; 34(4):1875-82. PubMed ID: 26238612
    [Abstract] [Full Text] [Related]

  • 14. Glaucocalyxin A-induced oxidative stress inhibits the activation of STAT3 signaling pathway and suppresses osteosarcoma progression in vitro and in vivo.
    Mao M, Zhang T, Wang Z, Wang H, Xu J, Yin F, Wang G, Sun M, Wang Z, Hua Y, Cai Z.
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun 01; 1865(6):1214-1225. PubMed ID: 30659925
    [Abstract] [Full Text] [Related]

  • 15. MicroRNA-216a inhibits pancreatic cancer by directly targeting Janus kinase 2.
    Wang S, Chen X, Tang M.
    Oncol Rep; 2014 Dec 01; 32(6):2824-30. PubMed ID: 25220761
    [Abstract] [Full Text] [Related]

  • 16. PARK2 inhibits osteosarcoma cell growth through the JAK2/STAT3/VEGF signaling pathway.
    Lei Z, Duan H, Zhao T, Zhang Y, Li G, Meng J, Zhang S, Yan W.
    Cell Death Dis; 2018 Mar 07; 9(3):375. PubMed ID: 29515107
    [Abstract] [Full Text] [Related]

  • 17. Clinical value of signal transducers and activators of transcription 3 (STAT3) gene expression in human osteosarcoma.
    Wang YC, Zheng LH, Ma BA, Zhou Y, Zhang MH, Zhang DZ, Fan QY.
    Acta Histochem; 2011 Jul 07; 113(4):402-8. PubMed ID: 20546860
    [Abstract] [Full Text] [Related]

  • 18. A sesquiterpene lactone antrocin from Antrodia camphorata negatively modulates JAK2/STAT3 signaling via microRNA let-7c and induces apoptosis in lung cancer cells.
    Yeh CT, Huang WC, Rao YK, Ye M, Lee WH, Wang LS, Tzeng DT, Wu CH, Shieh YS, Huang CY, Chen YJ, Hsiao M, Wu AT, Yang Z, Tzeng YM.
    Carcinogenesis; 2013 Dec 07; 34(12):2918-28. PubMed ID: 23880305
    [Abstract] [Full Text] [Related]

  • 19. Combination of AG490, a Jak2 inhibitor, and methylsulfonylmethane synergistically suppresses bladder tumor growth via the Jak2/STAT3 pathway.
    Joung YH, Na YM, Yoo YB, Darvin P, Sp N, Kang DY, Kim SY, Kim HS, Choi YH, Lee HK, Park KD, Cho BW, Kim HS, Park JH, Yang YM.
    Int J Oncol; 2014 Mar 07; 44(3):883-95. PubMed ID: 24402583
    [Abstract] [Full Text] [Related]

  • 20. Role of crosstalk between STAT3 and mTOR signaling in driving sensitivity to chemotherapy in osteosarcoma cell lines.
    Wang YT, Tang F, Hu X, Zheng CX, Gong TJ, Zhou Y, Luo Y, Min L.
    IUBMB Life; 2020 Oct 07; 72(10):2146-2153. PubMed ID: 33448097
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.